(Q44593595)

4 December 2017

Treatment of idiopathic CD4 T lymphocytopenia with IL-2. (English)

1 reference

Charlotte Cunningham-Rundles

4 December 2017

series ordinal

1

object named as

C Cunningham-Rundles

1 reference

4 December 2017

H W Murray

2

1 reference

PubMed ID

10337025

4 December 2017

J P Smith

series ordinal

3

1 reference

4 December 2017

1 May 1999

1 reference

Clinical and Experimental Immunology

4 December 2017

1 reference

4 December 2017

116

1 reference

4 December 2017

322-325

1 reference

4 December 2017

2

1 reference

Pharmacokinetics and pharmacodynamics of subcutaneous interleukin-2 in HIV-infected patients

4 December 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905283

Rational interleukin 2 therapy for HIV positive individuals: daily low doses enhance immune function without toxicity

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905283

Interleukin-2 and human immunodeficiency virus infection: pathogenic mechanisms and potential for immunologic enhancement

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905283

Apoptotic depletion of CD4+ T cells in idiopathic CD4+ T lymphocytopenia

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905283

Prolonged immunostimulatory effect of low-dose polyethylene glycol interleukin 2 in patients with human immunodeficiency virus type 1 infection

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905283

Idiopathic CD4+ T-lymphocytopenia--four patients with opportunistic infections and no evidence of HIV infection

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905283

Idiopathic CD4+ T-lymphocytopenia--an analysis of five patients with unexplained opportunistic infections

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905283

Idiopathic CD4+ T-lymphocytopenia--immunodeficiency without evidence of HIV infection

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905283

Unexplained opportunistic infections and CD4+ T-lymphocytopenia without HIV infection. An investigation of cases in the United States. The Centers for Disease Control Idiopathic CD4+ T-lymphocytopenia Task Force

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905283

Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905283

Acquired immunodeficiency without HIV infection: epidemiology and clinical outcome in Italy. The Italian Study Group on non-HIV AIDS.

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905283

Chemical modification of recombinant interleukin 2 by polyethylene glycol increases its potency in the murine Meth A sarcoma model

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905283

Interleukin-2: inception, impact, and implications

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905283

Recombinant interleukin 2 therapy in severe combined immunodeficiency disease

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905283

Interleukin 2 produced by activated B lymphocytes acts as an autocrine proliferation-inducing lymphokine

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905283

Restoration of immunoglobulin secretion in vitro in common variable immunodeficiency by in vivo treatment with polyethylene glycol-conjugated human recombinant interleukin-2

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905283

Acquired immunodeficiency without evidence of infection with human immunodeficiency virus types 1 and 2

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905283

Brief report: enhanced humoral immunity in common variable immunodeficiency after long-term treatment with polyethylene glycol-conjugated interleukin-2

27 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10337025

12 December 2020

inferred from PubMed ID database lookup

Immunologic effects of low-dose polyethylene glycol-conjugated recombinant human interleukin-2 in common variable immunodeficiency

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10337025

12 December 2020

inferred from PubMed ID database lookup

Regulation of cell growth by IL-2: role of STAT5 in protection from apoptosis but not in cell cycle progression

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10337025

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1046/J.1365-2249.1999.00886.X

1 reference

release_iv4keyyfvve6dly2gsh3qgpbti

4 December 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/iv4keyyfvve6dly2gsh3qgpbti

24 November 2022

mapped directly with Wikidata item

0 references

1 reference

PubMed ID

10337025